微生物与感染
Jan. 8, 2025   Home |  | About Journal | Editorial Board | Instruction | Publication Ethics | Subscriptions | Contacts Us | CHINESE
JOURNAL OF MICROBES AND INFECTIONS
Article Current Issue| Next Issue| Archive| Adv Search |
Differential analysis of DNA methylation profile between responder and nonresponder of interferon treatment in chronic hepatitis B patients
WU Min1, ZHANG Xiao-nan1, CHEN Jie-liang2, YUAN Zheng-hong1,2
1. Shanghai Public Health Clinical Center Affiliated to Fudan University, Shanghai 201508, China; 2. Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, School of Basic Medical Sciences, Fudan University, Shanghai 200032, China

Download: PDF (868 KB)   HTML (0)
Export: BibTeX | EndNote (RIS)      
Abstract  Interferon α (IFN­α) therapy remains a mainstay of treatment of chronic hepatitis B. However, sustained remission rates remain relatively low, and the search for factors important for response to therapy continues. In order to study the relationship between the genomic DNA methylation profile and response to interferon therapy in chronic hepatitis B, pretreatment plasma samples of 20 patients with chronic hepatitis B (CHB) receiving pegylated interferon α (PEG­IFNα) treatment were subjected to DNA methylation analyses using Roche­NimbleGen Human DNA Methylation 2.1M Deluxe Promoter v2 Array. Methylated DNA immunoprecipitation­quantitative polymerase chain reaction (MeDIP­qPCR) was used to further validate the methylation status of specific genes. A total of 588 genes were found to show differential methylation in interferon nonresponse group as compared with the rapid response group. These differential methylated genes were involved in several signaling pathways, such as the calcium signaling pathway, cell cycle and liver metabolism. The methylation levels of several genes in the two groups were confirmed by MeDIP­qPCR, consistent with the results of the MeDIP­chip study. Our data provide a foundation for future study on the functions of differential methylated genes in interferon response as well as the discovery of new molecular markers for predicting prognosis of interferon therapy in CHB patients.

Key wordsHepatitis B virus      Interferon      Methylation      DNA immunoprecipitation­chip     
Received: 23 July 2014      Published: 25 December 2014
Corresponding Authors: YUAN Zheng-hong   
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
WU Min1
ZHANG Xiao-nan1
CHEN Jie-liang2
YUAN Zheng-hong2
Cite this article:   
WU Min1,ZHANG Xiao-nan1,CHEN Jie-liang2等. Differential analysis of DNA methylation profile between responder and nonresponder of interferon treatment in chronic hepatitis B patients[J]. JOURNAL OF MICROBES AND INFECTIONS, 2014, 9(4): 217-223.
URL:  
http://jmi.fudan.edu.cn/EN/      OR     http://jmi.fudan.edu.cn/EN/Y2014/V9/I4/217
Copyright © 2010  Editorial Board of Chinese Academy of Medical Sciences (CAMS) and the Peking Union Medical College (PUMC)
Add:Editorial office of Acta Academiae Medicinae Sinicae , No.9 Dongdansantiao, Beijing PRC(100730)
Fax:010-65133074 E-mail:actacams@263.net.cn
Supported by:Beijing Magtech